Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Endocrine Disorders
Published in: BMC Endocrine Disorders 1/2019

Open Access 01-12-2019 | Type 2 Diabetes | Research article

Associations of serum low-density lipoprotein and systolic blood pressure levels with type 2 diabetic patients with and without peripheral neuropathy: systemic review, meta-analysis and meta-regression analysis of observational studies

Authors: Syed Shah Zaman Haider Naqvi, Saber Imani, Hossein Hosseinifard, Qing-Lian Wen, M. Naveed Shahzad, Iqra Ijaz, Youcai Deng, Man Guo, Yong Xu

Published in: BMC Endocrine Disorders | Issue 1/2019

Login to get access

Abstract

Background

Compositional abnormalities in lipoproteins and cardiovascular risk factors play an important role in the progression of diabetic peripheral neuropathy (DPN). This systematic review aimed to estimate the predicting value of low-density lipoprotein (LDL) and systolic blood pressure (SBP) level in type-2 diabetes mellitus (T2DM) patients with and without peripheral neuropathy. We also tried to determine whether LDL and SBP are associated with an increased collision risk of DPN.

Methods

A systematic search was conducted for eligible publications which explored the LDL and SBP level in T2DM patients with and without peripheral neuropathy. The quality of the included studies was assessed by the QUADAS-2 tool. The standardized mean difference (SMD) with 95% CI of LDL and SBP level were pooled to assess the correlation between LDL and SBP level with DPN. We performed random effects meta-regression analyses to investigate factors associated with an increased collision risk of DPN.

Results

There was a significant association between LDL and SBP with poor prognosis of DPN in those included studies (I2 = 88.1% and I2 = 84.9%, respectively, Both P < 0.001). European T2DM patients have higher serum level of LDL in compare with the European DPN patients (SMD = 0.16, 95% CI: − 0.06 - 0.38; P < 0.001). SBP level was associated with a 2.6-fold decrease in non-DPN patients of T2DM (SMD = − 2.63, 95% CI: − 4.00 - -1.27, P < 0.001). Old age European T2DM patients have significantly high risk for diabetes drivers. Furthermore, the results of the case-control study design model are more precise to show the accuracy of SBP in Asian T2DM patients.

Conclusion

Our finding supports the LDL and SBP status could be associated with increased risk of peripheral neuropathy in T2DM patients.
Appendix
Available only for authorised users
Literature
1.
Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4–14.PubMedCrossRef
2.
Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36(2):150–4.PubMedCrossRef
3.
Boulton AJ, Malik RA, Arezzo JC, Sosenko JM. Diabetic somatic neuropathies. Diabetes Care. 2004;27(6):1458–86.PubMedCrossRef
4.
Zhao W, Zeng H, Zhang X, Liu F, Pan J, Zhao J, Zhao J, Li L, Bao Y, Liu F, et al. A high thyroid stimulating hormone level is associated with diabetic peripheral neuropathy in type 2 diabetes patients. Diabetes Res Clin Pract. 2016;115:122–9.PubMedCrossRef
5.
Wu F, Jing Y, Tang X, Li D, Gong L, Zhao H, He L, Li Q, Li R. Anemia: an independent risk factor of diabetic peripheral neuropathy in type 2 diabetic patients. Acta Diabetol. 2017;54(10):925–31.PubMedCrossRef
6.
Rosales-Hernandez A, Cheung A, Podgorny P, Chan C, Toth C. Absence of clinical relationship between oxidized low density lipoproteins and diabetic peripheral neuropathy: a case control study. Lipids Health Dis. 2014;13:32.PubMedPubMedCentralCrossRef
7.
Yang J, Yan PJ, Wan Q, Li H. Association between hemoglobin levels and diabetic peripheral neuropathy in patients with type 2 diabetes: a cross-sectional study using electronic health records. J Diabetes Res. 2017;2017:2835981.PubMedPubMedCentral
8.
Bilir B, Ekiz Bilir B, Yilmaz I, Soysal Atile N, Yildirim T, Kara SP, Gumustas SA, Orhan AE, Aydin M. Association of apelin, endoglin and endocan with diabetic peripheral neuropathy in type 2 diabetic patients. Eur Rev Med Pharmacol Sci. 2016;20(5):892–8.PubMed
9.
Pek SLT, Sum CF, Yeoh LY, Lee SBM, Tang WE, Lim SC, Tavintharan S. Association of apolipoprotein-CIII (apoC-III), endothelium-dependent vasodilation and peripheral neuropathy in a multi-ethnic population with type 2 diabetes. Metab Clin Exp. 2017;72:75–82.PubMedCrossRef
10.
Ji ZY, Li HF, Lei Y, Rao YW, Tan ZX, Liu HJ, Yao GD, Hou B, Sun ML. Association of adiponectin gene polymorphisms with an elevated risk of diabetic peripheral neuropathy in type 2 diabetes patients. J Diabetes Complicat. 2015;29(7):887–92.CrossRef
11.
Su JB, Zhao LH, Zhang XL, Cai HL, Huang HY, Xu F, Chen T, Wang XQ. HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients. Cardiovasc Diabetol. 2018;17(1):47.PubMedPubMedCentralCrossRef
12.
Zhang Y, Jiang Y, Shen X, Yan S. Can both normal and mildly abnormal albuminuria and glomerular filtration rate be a danger signal for diabetic peripheral neuropathy in type 2 diabetes mellitus? Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2017;38(8):1381–90.CrossRef
13.
Won JC, Kwon HS, Kim CH, Lee JH, Park TS, Ko KS, Cha BY. Prevalence and clinical characteristics of diabetic peripheral neuropathy in hospital patients with type 2 diabetes in Korea. Diabetic medicine : a journal of the British Diabetic Association. 2012;29(9):e290–6.CrossRef
14.
Bansal D, Gudala K, Muthyala H, Esam HP, Nayakallu R, Bhansali A. Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting. J Diabetes Investig. 2014;5(6):714–21.PubMedPubMedCentralCrossRef
15.
Buraczynska M, Buraczynska K, Dragan M, Ksiazek A. Pro198Leu polymorphism in the glutathione peroxidase 1 gene contributes to diabetic peripheral neuropathy in type 2 diabetes patients. NeuroMolecular Med. 2017;19(1):147–53.PubMedCrossRef
16.
Luo YY, Zhao J, Han XY, Zhou XH, Wu J, Ji LN. Relationship between serum zinc level and microvascular complications in patients with type 2 diabetes. Chin Med J. 2015;128(24):3276–82.PubMedPubMedCentralCrossRef
17.
Ren Z, Ji N, Jia K, Wang L, Gu HF, Ma J. Association of the intercellular adhesion molecule-1 gene polymorphisms with type 2 diabetes and diabetic peripheral neuropathy in a Chinese Han population. Genes & Genomics. 2015;37(1):69–75.CrossRef
18.
Yu M, Zhang X, Lu F, Fang L. Depression and risk for diabetes: a Meta-analysis. Can J Diabetes. 2015;39(4):266–72.PubMedCrossRef
19.
Waller JA. Chronic medical conditions and traffic safety: review of the California experience. N Engl J Med. 1965;273(26):1413–20.PubMedCrossRef
20.
21.
Qu GB, Wang LL, Tang X, Wu W, Sun YH. The association between vitamin D level and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus: an update systematic review and meta-analysis. Journal of clinical & translational endocrinology. 2017;9:25–31.CrossRef
22.
Fei Mao XZ, Liu S, Qiao X, Zheng H, Lu B, Li Y. Age as an Independent Risk Factor for Diabetic Peripheral Neuropathy in Chinese Patients with Type 2 Diabetes. Aging Dis. 2019;10:592–600.PubMedPubMedCentralCrossRef
23.
Richardson WS, Wilson MC, Nishikawa J, Hayward RS. The well-built clinical question: a key to evidence-based decisions. ACP J Club. 1995;123(3):A12–3.PubMed
24.
Panic N, Leoncini E, de Belvis G, Ricciardi W, Boccia S. Evaluation of the endorsement of the preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement on the quality of published systematic review and meta-analyses. PLoS One. 2013;8(12):e83138.PubMedPubMedCentralCrossRef
25.
Imani S, Hosseinifard H, Cheng J, Wei C, Fu J. Prognostic value of EMT-inducing transcription factors (EMT-TFs) in metastatic breast Cancer: a systematic review and Meta-analysis. Sci Rep. 2016;6:28587.PubMedPubMedCentralCrossRef
26.
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.PubMedCrossRef
27.
Guise JM, Butler ME, Chang C, Viswanathan M, Pigott T, Tugwell P, Complex Interventions W. AHRQ series on complex intervention systematic reviews-paper 6: PRISMA-CI extension statement and checklist. J Clin Epidemiol. 2017;90:43–50.PubMedCrossRef
28.
Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM. Group Q-: QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–36.PubMedCrossRef
29.
Imani S, Zhang X, Hosseinifard H, Fu S, Fu J. The diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis. Oncotarget. 2017;8(14):23177–87.PubMedPubMedCentralCrossRef
30.
31.
Munafo MR, Clark TG, Flint J. Assessing publication bias in genetic association studies: evidence from a recent meta-analysis. Psychiatry Res. 2004;129(1):39–44.PubMedCrossRef
32.
33.
Lin X, Xu L, Zhao D, Luo Z, Pan S. Correlation between serum uric acid and diabetic peripheral neuropathy in T2DM patients. J Neurol Sci. 2018;385:78–82.PubMedCrossRef
34.
Qiao X, Zheng H, Zhang S, Liu S, Xiong Q, Mao F, Zhang Z, Wen J, Ye H, Li Y, et al. C-peptide is independent associated with diabetic peripheral neuropathy: a community-based study. Diabetol Metab Syndr. 2017;9:12.PubMedPubMedCentralCrossRef
35.
Sadosky A, Mardekian J, Parsons B, Hopps M, Bienen EJ, Markman J. Healthcare utilization and costs in diabetes relative to the clinical spectrum of painful diabetic peripheral neuropathy. J Diabetes Complicat. 2015;29(2):212–7.CrossRef
36.
Hu YM, Zhao LH, Zhang XL, Cai HL, Huang HY, Xu F, Chen T, Wang XQ, Guo AS, Li JA, et al. Association of glycaemic variability evaluated by continuous glucose monitoring with diabetic peripheral neuropathy in type 2 diabetic patients. Endocrine. 2018;60(2):292–300.PubMedCrossRef
37.
Khawaja N, Abu-Shennar J, Saleh M, Dahbour SS, Khader YS, Ajlouni KM. The prevalence and risk factors of peripheral neuropathy among patients with type 2 diabetes mellitus; the case of Jordan. Diabetol Metab Syndr. 2018;10:8.PubMedPubMedCentralCrossRef
38.
Zhang Q, Ji L, Zheng H, Li Q, Xiong Q, Sun W, Zhu X, Li Y, Lu B, Liu X, et al. Low serum phosphate and magnesium levels are associated with peripheral neuropathy in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2018;146:1–7.PubMedCrossRef
39.
Janghorbani M, Rezvanian H, Kachooei A, Ghorbani A, Chitsaz A, Izadi F, Amini M. Peripheral neuropathy in type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk factors. Acta Neurol Scand. 2006;114(6):384–91.PubMedCrossRef
40.
Kim SS, Won JC, Kwon HS, Kim CH, Lee JH, Park TS, Ko KS, Cha BY. Prevalence and clinical implications of painful diabetic peripheral neuropathy in type 2 diabetes: results from a nationwide hospital-based study of diabetic neuropathy in Korea. Diabetes Res Clin Pract. 2014;103(3):522–9.PubMedCrossRef
41.
Andersen ST, Witte DR, Dalsgaard EM, Andersen H, Nawroth P, Fleming T, Jensen TM, Finnerup NB, Jensen TS, Lauritzen T, et al. Risk factors for incident diabetic polyneuropathy in a cohort with screen-detected type 2 diabetes followed for 13 years: ADDITION-Denmark. Diabetes Care. 2018;41(5):1068–75.PubMedCrossRef
42.
Tentolouris A, Eleftheriadou I, Grigoropoulou P, Kokkinos A, Siasos G, Ntanasis-Stathopoulos I, Tentolouris N. The association between pulse wave velocity and peripheral neuropathy in patients with type 2 diabetes mellitus. J Diabetes Complicat. 2017;31(11):1624–9.CrossRef
43.
Xu T, Weng Z, Pei C, Yu S, Chen Y, Guo W, Wang X, Luo P, Sun J. The relationship between neutrophil-to-lymphocyte ratio and diabetic peripheral neuropathy in type 2 diabetes mellitus. Medicine. 2017;96(45):e8289.PubMedPubMedCentralCrossRef
44.
Zhu T, Meng Q, Ji J, Lou X, Zhang L. Toll-like receptor 4 and tumor necrosis factor-alpha as diagnostic biomarkers for diabetic peripheral neuropathy. Neurosci Lett. 2015;585:28–32.PubMedCrossRef
45.
Deng W, Dong X, Zhang Y, Jiang Y, Lu D, Wu Q, Liang Z, Yang G, Chen B. Transcutaneous oxygen pressure (TcPO (2)): a novel diagnostic tool for peripheral neuropathy in type 2 diabetes patients. Diabetes Res Clin Pract. 2014;105(3):336–43.PubMedCrossRef
46.
Santos TRM, Melo JV, Leite NC, Salles GF, Cardoso CRL. Usefulness of the vibration perception thresholds measurement as a diagnostic method for diabetic peripheral neuropathy: results from the Rio de Janeiro type 2 diabetes cohort study. J Diabetes Complicat. 2018;32(8):770–6.CrossRef
47.
Miric DJ, Kisic BM, Filipovic-Danic S, Grbic R, Dragojevic I, Miric MB, Puhalo-Sladoje D. Xanthine oxidase activity in type 2 diabetes mellitus patients with and without diabetic peripheral neuropathy. J Diabetes Res. 2016;2016:4370490.PubMedPubMedCentralCrossRef
48.
Hussain G, Rizvi SA, Singhal S, Zubair M, Ahmad J. Cross sectional study to evaluate the effect of duration of type 2 diabetes mellitus on the nerve conduction velocity in diabetic peripheral neuropathy. Diabetes & metabolic syndrome. 2014;8(1):48–52.CrossRef
49.
Li L, Chen J, Wang J, Cai D. Prevalence and risk factors of diabetic peripheral neuropathy in type 2 diabetes mellitus patients with overweight/obese in Guangdong province, China. Primary care diabetes. 2015;9(3):191–5.PubMedCrossRef
50.
Pai YW, Lin CH, Lee IT, Chang MH. Prevalence and biochemical risk factors of diabetic peripheral neuropathy with or without neuropathic pain in Taiwanese adults with type 2 diabetes mellitus. Diabetes & metabolic syndrome. 2018;12(2):111–6.CrossRef
51.
Xu F, Zhao LH, Su JB, Chen T, Wang XQ, Chen JF, Wu G, Jin Y, Wang XH. The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c. Diabetol Metab Syndr. 2014;6(1):139.PubMedPubMedCentralCrossRef
52.
Wang H, Fan D, Zhang Y. Angiogenin gene polymorphism: a risk factor for diabetic peripheral neuropathy in the northern Chinese Han population. Neural Regen Res. 2013;8(36):3434–40.PubMedPubMedCentral
53.
Wang H, Fan D, Hong T. Is the C677T polymorphism in methylenetetrahydrofolate reductase gene or plasma homocysteine a risk factor for diabetic peripheral neuropathy in Chinese individuals? Neural Regen Res. 2012;7(30):2384–91.PubMedPubMedCentral
54.
Pai YW, Lin CH, Lee IT, Chang MH. Variability of fasting plasma glucose and the risk of painful diabetic peripheral neuropathy in patients with type 2 diabetes. Diabetes Metab. 2018;44(2):129–34.PubMedCrossRef
55.
Hoque S, A Muttalib M, Islam M, Happy T: Evaluation of Different HbA1c Levels to Assess the Risk of Peripheral Neuropathy Among Type 2 Diabetic Patients Along With Other Conventional Risk Factors, vol. 42; 2017.
56.
Tobias A. Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull. 1999;8(1):15–7.
57.
Jaiswal M, Divers J, Dabelea D, Isom S, Bell RA, Martin CL, Pettitt DJ, Saydah S, Pihoker C, Standiford DA, et al. Prevalence of and risk factors for diabetic peripheral neuropathy in youth with type 1 and type 2 diabetes: SEARCH for diabetes in youth study. Diabetes Care. 2017;40(9):1226–32.PubMedPubMedCentralCrossRef
58.
Phelan S, Kanaya AM, Subak LL, Hogan PE, Espeland MA, Wing RR, Burgio KL, Dilillo V, Gorin AA, West DS, et al. Prevalence and risk factors for urinary incontinence in overweight and obese diabetic women: action for health in diabetes (look ahead) study. Diabetes Care. 2009;32(8):1391–7.PubMedPubMedCentralCrossRef
59.
Yamada E, Namiki Y, Takano Y, Takamine H, Inazumi K, Sasaki H, Yamada M, Ito S, Iwasaki T, Mantani N, et al. Clinical factors associated with the symptoms of constipation in patients with diabetes mellitus: a multicenter study. J Gastroenterol Hepatol. 2018;33(4):863–8.PubMedCrossRef
Metadata
Title
Associations of serum low-density lipoprotein and systolic blood pressure levels with type 2 diabetic patients with and without peripheral neuropathy: systemic review, meta-analysis and meta-regression analysis of observational studies
Authors
Syed Shah Zaman Haider Naqvi
Saber Imani
Hossein Hosseinifard
Qing-Lian Wen
M. Naveed Shahzad
Iqra Ijaz
Youcai Deng
Man Guo
Yong Xu
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Type 2 Diabetes
Published in
BMC Endocrine Disorders / Issue 1/2019
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-019-0453-5

Other articles of this Issue 1/2019

BMC Endocrine Disorders 1/2019 Go to the issue

Research article

Effectiveness of monthly and bimonthly follow-up of patients with well-controlled type 2 diabetes: a propensity score matched cohort study

Research article

Association of major dietary patterns and different metabolic phenotypes: a population-based study of northwestern Iran

Research article

Mobile health in the management of type 1 diabetes: a systematic review and meta-analysis

Research article

“I have got diabetes!” – interviews of patients newly diagnosed with type 2 diabetes

Research article

Altered expression of DLG1-AS1 distinguished papillary thyroid carcinoma from benign thyroid nodules

Research article

Association between renal function and bone mineral density in healthy postmenopausal Chinese women

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits